New Weight-Loss Drug Looks Good in Trial

A newly approved drug for type 2 diabetes may be a game-changer for treating obesity, too. Given as a shot once a week, tirzepatide works…
Read onA newly approved drug for type 2 diabetes may be a game-changer for treating obesity, too. Given as a shot once a week, tirzepatide works…
Read onDropping a load of pounds through weight-loss surgery can significantly decrease your risk of developing or dying from cancer, according to three new studies. Obese…
Read onAs the weather warms and families flock to pools, dirty water may dampen the fun. Swimmers at a Pennsylvania community pool learned that the hard…
Read onWomen are more apt to use birth control when doctors treat it like a routine preventive health service, a new research review shows. The analysis…
Read onGiving antibiotics to a woman just before a cesarean delivery does not increase her baby’s risk of asthma or eczema, a new British study says.…
Read onIt’s a good idea to get children outside every day, but especially on Kids to Parks Day, a national day of outdoor play on May…
Read onWith Roe v. Wade hanging in the balance and nearly half of all American states ready to practically ban abortion if the leaked draft opinion…
Read onRates of dangerous high blood pressure problems during pregnancy more than doubled in the United States between 2007 and 2019, a new study finds. “The…
Read onIt’s never too late to start exercising — and the right activities might help you stay independent in your home. While building healthy habits at…
Read onIs an upcoming final exam or big-time job interview stressing you out? Hug your honey. That’s the takeaway from new research that showed how embracing…
Read onHormone replacement therapy may offer women significant protection against dying from COVID-19, new research suggests. British researchers who tracked more than 5,400 women with COVID…
Read onRates of childhood obesity in the United States are soaring, and new research suggests child care programs may be part of the problem. Most tots…
Read on